Yarrow Bioscience, Inc. (YARW)
13.48
-0.75
(-5.27%)
USD |
NASDAQ |
Nov 20, 12:14
Yarrow Bioscience Free Cash Flow : -99.79M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -99.79M |
| June 30, 2026 | -16.93M |
| March 31, 2026 | -25.74M |
| December 31, 2025 | -33.12M |
| September 30, 2025 | -38.48M |
| June 30, 2025 | -39.89M |
| March 31, 2025 | -37.57M |
| December 31, 2024 | -34.09M |
| September 30, 2024 | -30.11M |
| June 30, 2024 | -26.75M |
| March 31, 2024 | -27.84M |
| December 31, 2023 | -25.34M |
| September 30, 2023 | -24.08M |
| June 30, 2023 | -26.05M |
| March 31, 2023 | -24.70M |
| December 31, 2022 | -29.20M |
| September 30, 2022 | -35.34M |
| June 30, 2022 | -45.76M |
| March 31, 2022 | -53.79M |
| Date | Value |
|---|---|
| December 31, 2021 | -56.37M |
| September 30, 2021 | -71.72M |
| June 30, 2021 | -77.82M |
| March 31, 2021 | -97.49M |
| December 31, 2020 | -137.20M |
| September 30, 2020 | -134.26M |
| June 30, 2020 | -132.82M |
| March 31, 2020 | -109.92M |
| December 31, 2019 | -74.45M |
| September 30, 2019 | -68.65M |
| June 30, 2019 | -58.15M |
| March 31, 2019 | -58.08M |
| December 31, 2018 | -52.73M |
| September 30, 2018 | -46.31M |
| June 30, 2018 | -46.67M |
| March 31, 2018 | -33.98M |
| December 31, 2017 | -28.27M |
| September 30, 2017 | -22.62M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Cypherpunk Technologies, Inc. | -132.19M |
| Cue Biopharma, Inc. | -51.22M |
| Faeth Therapeutics, Inc. | -43.28M |
| Indaptus Therapeutics, Inc. | -13.97M |
| Pyxis Oncology, Inc. | -70.93M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -89.96M |
| Cash from Investing (Quarterly) | -5.00M |
| Cash from Financing (Quarterly) | 265.03M |
| Free Cash Flow Per Share (Quarterly) | -3.982 |
| Free Cash Flow to Equity (Quarterly) | -89.96M |
| Free Cash Flow to Firm (Quarterly) | -89.96M |
| Free Cash Flow Yield | -64.52% |